SOFWF (Sofwave Medical) ROCE %: 22.35% (As of Mar. 2026)

What is Sofwave Medical ROCE %?

Sofwave Medical SOFWF 48 ROCE % is 22.35% as of Mar. 2026. GuruFocus rates SOFWF with a GF Score™ of 48/100 and a GF Value™ of $11.23 (Significantly Overvalued). The stock has 2 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Sofwave Medical's annualized ROCE % for the quarter that ended in Mar. 2026 was 22.35%.

Sofwave Medical (OTCPK:SOFWF) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Sofwave Medical ROCE % Related Terms

Sofwave Medical ROCE % Historical Data

* Premium members only.

The historical data trend for Sofwave Medical's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sofwave Medical ROCE % Chart

Sofwave Medical Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

ROCE %

Get a 7-Day Free Trial

-26.38

-45.22

-26.71

-15.12

19.69

Sofwave Medical Quarterly Data
	Dec19	Dec20	Jun21	Dec21	Mar22	Jun22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
ROCE %	Get a 7-Day Free Trial															-10.90	34.87	23.72	33.82	22.35

48GF Score

Sofwave Medical Ltd SOFWF

ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Sofwave Medical ROCE % Calculation

Sofwave Medical's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2025 )		(A: Dec. 2024 )		(A: Dec. 2025 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2025 )		(A: Dec. 2024 )		(A: Dec. 2025 )
	=	5.805	/	( ( (43.029 - 17.502)	+	(55.769 - 22.332) )	/ 2 )
	=	5.805	/	( (25.527	+	33.437)	/ 2 )
	=	5.805	/	29.482
	=	19.69 %

Sofwave Medical's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2026 )		(Q: Dec. 2025 )		(Q: Mar. 2026 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2026 )		(Q: Dec. 2025 )		(Q: Mar. 2026 )
	=	7.772	/	( ( (55.769 - 22.332)	+	(57.743 - 21.635) )	/ 2 )
	=	7.772	/	( ( 33.437	+	36.108 )	/ 2 )
	=	7.772	/	34.7725
	=	22.35 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

Frequently Asked Questions Learn more about ROCE % →

What does a ROCE % of 22.35% mean?

Sofwave Medical (SOFWF) has a ROCE % of 22.35% as of Mar. 2026.

Is Sofwave Medical's ROCE % too high?

Sofwave Medical's current ROCE % is 22.35%. The Medical Devices & Instruments industry median ROCE % is 2.20. Sofwave Medical's value of 22.35% is 915.9% above this industry median. Overall, Sofwave Medical has a GF Score™ of 48/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.

How does Sofwave Medical's ROCE % compare to ABT and SYK?

Sofwave Medical's ROCE % of 22.35% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.20. Sofwave Medical's value of 22.35% is 915.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good ROCE % for a Medical Devices & Instruments company?

The median ROCE % among Medical Devices & Instruments companies is 2.20, based on 813 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sofwave Medical's current ROCE % of 22.35% is 915.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high ROCE % mean?

A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sofwave Medical's current ROCE % is 22.35%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Sofwave Medical stock overvalued right now?

Based on GuruFocus' analysis, Sofwave Medical (SOFWF) is currently considered Significantly Overvalued. The stock's GF Value™ is $11.23, compared to a current price of $16.00 — trading 42.5% above its estimated fair value. The current ROCE % is 22.35% and 915.9% above the Medical Devices & Instruments industry median of 2.20. Sofwave Medical's overall GF Score™ is 48/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is ROCE % calculated?

ROCE % is calculated from a company's financial statements. For Sofwave Medical (SOFWF), the current ROCE % is 22.35% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sofwave Medical (SOFWF) Overvalued in 2026?

Based on GuruFocus' analysis, Sofwave Medical stock appears to be overvalued. The current stock price of $16.00 is trading 42.5% above its estimated GF Value™ of $11.23. GuruFocus considers Sofwave Medical to be Significantly Overvalued.

Key valuation signals for SOFWF:

ROCE %: 22.35%
GF Value™: $11.23 vs. price of $16.00 (42.5% above fair value)
GF Score™: 48/100 with 2 warning signs
Industry Position: 915.9% above the Medical Devices & Instruments median

No single metric tells the full story. See the SOFWF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sofwave Medical Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies XTAE:BWAY XTAE:ILX XTAE:ABOU XTAE:EPIT XTAE:PLSM XTAE:ALMD XTAE:ERKA XTAE:BIOV XTAE:EFNC-M XTAE:HUMX-M ABT SYK MDT BSX EW XTER:SHL GEHC DXCM XAMS:PHIA SZSE:300760

Other Exchanges SOFW:Israel

Address Oak Medtech, Tavor, Alon Medtech Venture, Yokneam Illit, ISR, 2069200

Website https://sofwave.com

Sofwave Medical Ltd is engaged in the development, marketing, and production of non-invasive technology for skin rejuvenation and firming treatment.

48GF Score

Get the complete analysis for SOFWF

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$16.00

Price

$11.23

GF Value

View SOFWF Analysis

See ROCE % data for all stocks →